Myopia Completed Phase 4 Trials for Polyethylene glycol 400 (DB11077)

Also known as: Short-sighted / Short sightedness / Nearsighted

IndicationStatusPhase
DBCOND0009460 (Myopia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00627302Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision